SIOVHAN GRANT: Open Payments
NPI 1104499375 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 66 payments from 19 companies in 2025. Trend: 2023 $1,766 · 2024 $1,391 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 8 | $222 |
| GlaxoSmithKline, LLC. | 6 | $206 |
| ABBVIE INC. | 12 | $204 |
| Novo Nordisk Inc | 7 | $114 |
| PFIZER INC. | 6 | $108 |
| Astellas Pharma US Inc | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Exact Sciences Corporation | 3 | $52 |
| Sumitomo Pharma America, Inc. | 1 | $49 |
| Axsome Therapeutics, Inc. | 3 | $47 |
Products named: VOQUEZNA, AREXVY, VRAYLAR, NURTEC ODT, Veozah, TRELEGY ELLIPTA, QULIPTA, UBRELVY.
Industry payments across TX — which companies pay providers there.
